Clinical Trial Update: A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS) [Phase 1]

View source ↗

Summary

Phase 1 trial of oral clofarabine in adults with myelodysplastic Syndromes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: TERMINATED